GB-4542 (Gliknik)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGB-4542 (Gliknik)

Drug Alias NameStradobodiesStradomersGB-4542

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsComplement dependent cytotoxicity (CDC) effectsCD20-directed cytolytic effects +[4]

TargetsB-lymphocyte antigen CD20

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGliknik Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGliknik Inc

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A